Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patiromer in ESRD with Hyperkalemia
NCT03326583Phase 2Completed
- Start
- Nov 2017
- Primary completion
- Dec 2020
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of patiromer in hyperkalemia. Started Nov 2017; status: completed.
02
Drugs
patiromer
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT03326583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03326583.